John S. Markowitz

9.0k total citations
157 papers, 6.4k citations indexed

About

John S. Markowitz is a scholar working on Psychiatry and Mental health, Pharmacology and Pharmacology. According to data from OpenAlex, John S. Markowitz has authored 157 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Psychiatry and Mental health, 55 papers in Pharmacology and 36 papers in Pharmacology. Recurrent topics in John S. Markowitz's work include Attention Deficit Hyperactivity Disorder (33 papers), Pharmacogenetics and Drug Metabolism (30 papers) and Schizophrenia research and treatment (24 papers). John S. Markowitz is often cited by papers focused on Attention Deficit Hyperactivity Disorder (33 papers), Pharmacogenetics and Drug Metabolism (30 papers) and Schizophrenia research and treatment (24 papers). John S. Markowitz collaborates with scholars based in United States, China and Germany. John S. Markowitz's co-authors include C. Lindsay DeVane, Hao‐Jie Zhu, Kennerly S. Patrick, Jennifer L. Donovan, Heidi L. Liston, David W. Boulton, Kenneth D. Chavin, Jun-Sheng Wang, Arthur B. Straughn and Thea Moore and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

John S. Markowitz

150 papers receiving 6.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John S. Markowitz United States 49 2.3k 1.6k 1.4k 958 870 157 6.4k
C. Lindsay DeVane United States 46 1.8k 0.8× 1.3k 0.8× 1.2k 0.8× 1.2k 1.2× 773 0.9× 158 5.8k
Søren H. Sindrup Denmark 59 1.4k 0.6× 3.3k 2.1× 1.6k 1.2× 1.3k 1.3× 1.1k 1.3× 180 13.4k
Christoph Hiemke Germany 52 3.8k 1.6× 2.6k 1.6× 1.4k 1.0× 1.3k 1.3× 591 0.7× 406 11.5k
Achille P. Caputi Italy 60 820 0.4× 1.8k 1.2× 945 0.7× 743 0.8× 1.0k 1.2× 311 13.0k
Jerold S. Harmatz United States 65 2.7k 1.2× 2.4k 1.5× 4.0k 2.9× 1.7k 1.8× 1.7k 2.0× 236 11.8k
Nicholas M. P. King United States 53 1.1k 0.5× 1.2k 0.7× 1.2k 0.9× 1.1k 1.2× 620 0.7× 168 8.8k
Michael W. Jann United States 39 2.1k 0.9× 1.1k 0.7× 734 0.5× 748 0.8× 258 0.3× 133 5.1k
Christopher D. King United States 39 1.1k 0.5× 2.1k 1.3× 1.4k 1.0× 1.3k 1.4× 1.0k 1.2× 121 7.5k
Edoardo Spina Italy 58 5.0k 2.2× 2.0k 1.3× 2.5k 1.7× 2.1k 2.2× 915 1.1× 273 9.9k
Jules Desmeules Switzerland 42 808 0.4× 1.3k 0.8× 1.9k 1.3× 956 1.0× 802 0.9× 240 6.4k

Countries citing papers authored by John S. Markowitz

Since Specialization
Citations

This map shows the geographic impact of John S. Markowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Markowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Markowitz more than expected).

Fields of papers citing papers by John S. Markowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Markowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Markowitz. The network helps show where John S. Markowitz may publish in the future.

Co-authorship network of co-authors of John S. Markowitz

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Markowitz. A scholar is included among the top collaborators of John S. Markowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Markowitz. John S. Markowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Markowitz, John S., Lindsay M. Squeglia, Jarrod M. Ellingson, et al.. (2024). Evidence for sex differences in the impact of cytochrome P450 genotypes on early subjective effects of cannabis. Addictive Behaviors. 153. 107996–107996. 5 indexed citations
2.
Zhang, Qingchen, et al.. (2023). An in vitro evaluation of kratom (Mitragyna speciosa) on the catalytic activity of carboxylesterase 1 (CES1). Chemico-Biological Interactions. 384. 110715–110715. 3 indexed citations
3.
Zhang, Qingchen, et al.. (2022). In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir. Chemico-Biological Interactions. 365. 110097–110097. 8 indexed citations
4.
Qian, Yuli, et al.. (2022). Involvement of esterases in the pulmonary metabolism of beclomethasone dipropionate and the potential influence of cannabis use. Chemico-Biological Interactions. 368. 110228–110228. 3 indexed citations
5.
Davoudi, Alireza, et al.. (2021). Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-blind, Randomized, Controlled Clinical Trial. Clinical Therapeutics. 43(6). 1007–1019. 44 indexed citations
6.
Steingard, Ronald J., Sarper Taşkıran, Daniel F. Connor, John S. Markowitz, & Mark A. Stein. (2019). New Formulations of Stimulants: An Update for Clinicians. Journal of Child and Adolescent Psychopharmacology. 29(5). 324–339. 33 indexed citations
7.
Markowitz, John S. & Kennerly S. Patrick. (2017). The Clinical Pharmacokinetics of Amphetamines Utilized in the Treatment of Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 27(8). 678–689. 32 indexed citations
8.
Albassam, Ahmed A., Reginald F. Frye, & John S. Markowitz. (2017). The effect of milk thistle (Silybum marianum) and its main flavonolignans on CYP2C8 enzyme activity in human liver microsomes. Chemico-Biological Interactions. 271. 24–29. 19 indexed citations
9.
Yu, Guo, Guo‐Fu Li, & John S. Markowitz. (2016). Atomoxetine: A Review of Its Pharmacokinetics and Pharmacogenomics Relative to Drug Disposition. Journal of Child and Adolescent Psychopharmacology. 26(4). 314–326. 70 indexed citations
10.
Markowitz, John S., Hao‐Jie Zhu, & Kennerly S. Patrick. (2013). Isopropylphenidate: An Ester Homolog of Methylphenidate with Sustained and Selective Dopaminergic Activity and Reduced Drug Interaction Liability. Journal of Child and Adolescent Psychopharmacology. 23(10). 648–654. 10 indexed citations
11.
Brinda, Bryan J., et al.. (2012). A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples. Biomedical Chromatography. 26(11). 1364–1370. 9 indexed citations
12.
Brinda, Bryan J., Hao‐Jie Zhu, & John S. Markowitz. (2012). A sensitive LC–MS/MS assay for the simultaneous analysis of the major active components of silymarin in human plasma. Journal of Chromatography B. 902. 1–9. 44 indexed citations
13.
Wang, Jun-Sheng, Hao‐Jie Zhu, Jennifer L. Donovan, et al.. (2009). Aripiprazole brain concentration is altered in P-glycoprotein deficient mice. Schizophrenia Research. 110(1-3). 90–94. 30 indexed citations
14.
Wang, Junsheng, et al.. (2008). Antipsychotic Drugs Inhibit the Function of Breast Cancer Resistance Protein. Basic & Clinical Pharmacology & Toxicology. 103(4). 336–341. 50 indexed citations
15.
Markowitz, John S. & Kennerly S. Patrick. (2008). Introduction. Journal of Clinical Psychopharmacology. 28(3). S37–S38.
16.
Markowitz, John S., C. Lindsay DeVane, Linda Pestreich, Kennerly S. Patrick, & Rafael Muniz. (2006). A Comprehensive In Vitro Screening of d-, l- , and dl-threo -Methylphenidate: An Exploratory Study. Journal of Child and Adolescent Psychopharmacology. 16(6). 687–698. 85 indexed citations
17.
Markowitz, John S., C. Lindsay DeVane, Robert Malcolm, et al.. (2006). Pharmacokinetics of Olanzapine After Single‐Dose Oral Administration of Standard Tablet Versus Normal and Sublingual Administration of an Orally Disintegrating Tablet in Normal Volunteers. The Journal of Clinical Pharmacology. 46(2). 164–171. 52 indexed citations
18.
Wang, Junsheng, Ying Ruan, Robin M. Taylor, et al.. (2004). Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood?brain barrier of Abcb1a gene knockout mice. Psychopharmacology. 173(1-2). 132–138. 91 indexed citations
19.
Markowitz, John S., C. Lindsay DeVane, David W. Boulton, et al.. (2000). Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sciences. 66(9). PL133–PL139. 114 indexed citations
20.
Myrick, Hugh, John S. Markowitz, & Scott Henderson. (1998). Priapism following trazodone overdose with cocaine use.. Annals of Clinical Psychiatry. 10(2). 81–83. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Lindsay DeVane Breakdown of academic impact, for papers by Søren H. Sindrup Breakdown of academic impact, for papers by Christoph Hiemke Breakdown of academic impact, for papers by Achille P. Caputi Breakdown of academic impact, for papers by Jerold S. Harmatz Breakdown of academic impact, for papers by Nicholas M. P. King Breakdown of academic impact, for papers by Michael W. Jann Breakdown of academic impact, for papers by Christopher D. King Breakdown of academic impact, for papers by Edoardo Spina Breakdown of academic impact, for papers by Jules Desmeules
Rankless by CCL
2026